A Study in Adults With Inflammatory Bowel Disease (IBD) Receiving Vedolizumab in the Patient Support Program (PSP) in Brazil
Clinical trial NCT05626088 · COMPLETED
Trial details
- NCT number
- NCT05626088
- Sponsor
- Takeda
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2023-04-10
- Primary completion
- 2024-12-27
- Enrollment
- 1006
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.